Ocugen (MEX:OCGN) Cyclically Adjusted PB Ratio: (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OCGN Ocugen Inc MEX:OCGN
35 GF Score
Price MXN23.18
GF Value MXN14.53
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ocugen  (MEX:OCGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ocugen Cyclically Adjusted PB Ratio Related Terms


Ocugen Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Ocugen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen Cyclically Adjusted PB Ratio Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.03 0.03 0.50

Ocugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.08 0.23 0.50 0.00

MEX:OCGN vs EVMN, PBYI, LRMR: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Ocugen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ocugen's Cyclically Adjusted PB Ratio falls into.


MEX:OCGN
35GF Score
Ocugen Inc MEX:OCGN
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ocugen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Ocugen's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.309/330.2130*330.2130
=0.309

Current CPI (Mar. 2026) = 330.2130.

Ocugen Quarterly Data

Book Value per Share CPI Adj_Book
201606 1,078.566 241.018 1,477.717
201609 294.483 241.428 402.779
201612 813.113 241.432 1,112.116
201703 355.762 243.801 481.857
201706 39.270 244.955 52.938
201709 -229.858 246.819 -307.521
201712 -539.751 246.524 -722.984
201803 -762.812 249.554 -1,009.362
201806 -959.469 251.989 -1,257.313
201809 -310.446 252.439 -406.091
201812 -8.697 251.233 -11.431
201903 -68.047 254.202 -88.394
201906 -106.349 256.143 -137.102
201909 -25.812 256.759 -33.196
201912 3.949 256.974 5.074
202003 3.251 258.115 4.159
202006 2.500 257.797 3.202
202009 1.966 260.280 2.494
202012 2.330 260.474 2.954
202103 5.050 264.877 6.296
202106 11.662 271.696 14.174
202109 11.071 274.310 13.327
202112 9.858 278.802 11.676
202203 12.108 287.504 13.907
202206 10.620 296.311 11.835
202209 8.847 296.808 9.843
202212 6.509 296.797 7.242
202303 6.034 301.836 6.601
202306 4.698 305.109 5.085
202309 3.966 307.789 4.255
202312 2.684 306.746 2.889
202403 1.952 312.332 2.064
202406 1.205 314.175 1.267
202409 2.756 315.301 2.886
202412 2.121 315.605 2.219
202503 1.115 319.799 1.151
202506 0.197 322.561 0.202
202509 0.208 324.800 0.211
202512 -0.701 324.054 -0.714
202603 0.309 330.213 0.309

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ocugen (MEX:OCGN) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of MXN23.18 is trading 59.5% above its estimated GF Value™ of MXN14.53. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for MEX:OCGN:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: MXN14.53 vs. price of MXN23.18 (59.5% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the MEX:OCGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ocugen Business Description

Other Exchanges OCGN:USA2H51:Germany
Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
35GF Score

Get the complete analysis for MEX:OCGN

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN23.18
Price
MXN14.53
GF Value